IGC Share Price

IGC Share Price

AMEX: IGC | Micro Cap | Healthcare
$0.20
+$0.01 (8.00%) Last updated on 19 Nov, 2026 | 01:21 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

IGC Stock Performance

Open
$0.19
Prev. Close
$0.18
Circuit Range
N/A
Day Range
$0.19 - $0.20
Year Range
$0.08 - $0.36
Volume
1,200
Average Traded
$0.20

IGC Share Price Today

As of 19 November 2026, IGC Pharma, Inc.'s share price is $0.20. The stock opened at $0.19, compared to its previous close of $0.18. During today's trading session, IGC Pharma, Inc.'s share price traded between $0.19 and $0.20, with an average price of $0.19. Over the past 52 weeks, the stock has recorded a high of $0.36 and a low of $0.08. In terms of performance, IGC Pharma, Inc.'s share price has declined by 31.57% over the last six months and is down 38.26% on a year-on-year basis.

IGC Share Price Chart

Line chart of the IGC price trend over the selected period. The price rose overall, ranging from 0.19 to 0.20, ending at 0.20.
$0.19$0.20
L
Show Current Price
H

IGC Stock Fundamentals & Key Indicators

Market Cap
$14.97M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.08
Revenue (TTM)
$1.27B
Return On Equity (TTM)
-141.59%
Profit Margin
-560.63%
Debt to Equity
0.13
Quarterly Earnings Growth YoY
-60.66%

IGC Quarterly Profit & Loss

All figures in USD

ParticularsDec 2024Mar 2025Mar 2026Jun 2026
Revenue$0.26$0.33$0.32$0.27
Net Profit-$1.83-$1.20-$2.40-$2.94
Net Profit Margin-703.85%-363.64%-750.00%-1088.89%
Income ChangeN/A34.43%-100.00%-22.50%

IGC Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.40$0.91$1.35$1.27
Net Profit-$15.02-$11.51-$13.00-$7.12
Net Profit Margin-3755.00%-1264.84%-962.96%-560.63%
Income ChangeN/A23.37%-12.95%45.23%

IGC Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets7.926.210.7111.72
Current Assets1.793.716.4715.11
Total Assets9.719.917.1826.83
Non Current Liabilities0.130.240.370.5
Current Liabilities2.162.341.92.44
Total Liabilities2.292.582.272.94
Shareholders' Equity7.427.3214.9123.89

IGC Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-4.8-5.2-7.05-7.46
Investing-0.44-0.32-0.24-0.74
Financing4.453.520.14.14

About IGC

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

IGC Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.19
$0.20
+7.73%
Oct 2026
$0.28
$0.18
-33.21%
Sep 2026
$0.30
$0.27
-18.37%
Aug 2026
$0.25
$0.33
+36.63%
Jul 2026
$0.27
$0.24
-10.99%
Jun 2026
$0.28
$0.27
-4.55%
May 2026
$0.33
$0.29
-9.78%
Apr 2026
$0.27
$0.32
+23.83%
Mar 2026
$0.27
$0.26
-7.91%
Feb 2026
$0.27
$0.28
+2.21%
Jan 2026
$0.28
$0.27
-2.16%
Dec 2025
$0.32
$0.28
-12.30%

IGC Share Price FAQs